Skip to main content
Back to HSG

HSG's Therapeutics Portfolio

Browse 4 Therapeutics companies funded by HSG. See funding amounts, founder contacts, and investment details.

Therapeutics Companies
4
Total Funding in Therapeutics
$258.0M

Therapeutics Portfolio Companies (4)

Export
BiotechnologyMedicalOncologyTherapeutics

Normunity develops precision immuno-oncology medicines that enable normal immunity against cancer.

New Haven, United States
January 2025
$75.0M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyOncologyTherapeutics

ProfoundBio is a developer of targeted therapeutics intended for patients with cancer.

Seattle, United States
February 2024
$112.0M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyLife ScienceMedicalTherapeutics

Proviva Therapeutics is a pro-drug design platform for cytokines and other fusion proteins.

Shanghai, China
December 2025
$30.0M
Series A

Founder Contacts

19,000+ verified contacts

Therapeutics

Excalipoint Therapeutics is a Private limited company.

Admiralty, Hong Kong
August 2025
$41.0M
Series A

Founder Contacts

19,000+ verified contacts

Explore HSG's Full Portfolio

View all companies funded by HSG across every industry and funding stage.

View Full HSG Portfolio